TPBG and nasopharyngeal carcinoma: Moreover, the predominant membrane localization of 5T4 on NPC cells (Supplementary Fig. S2) and its selective expression on NPC tissues further indicated that it can be applied for CAR-redirected anti-NPC immunotherapy.